Wedge Capital Management L L P NC has sold
17,868 shares of
Laboratory Co. of America Holdings (NYSE:LH) . Concurrently,
Labcorp has declared its
quarterly cash dividend for 2025 and announces
first quarter results for 2024. Following mixed financial reports,
Labcorp's current share price is being scrutinized and compared with its financials. Despite this,
Labcorp's stock hit a
52-week high of
$238.93, before further increasing to
$239.65. Recently, additional
shares of Labcorp were bought by
Pinnacle Bancorp Inc and
Nordea Investment Management AB. However, the company's
debt ratio and CEO compensation package have raised concerns. In terms of acquisitions, Labcorp has acquired select assets from
Invitae and
BioReference Health's Diagnostics Business. The company continues to innovate with new advances, notably the launch of the
Labcorp® Plasma Detect™, expanding leadership into molecular residual disease research. It has also received
FDA emergency use authorization for its Mpox PCR test home collection kit, and approval for a companion diagnostic for Pfizer's newly approved gene therapy to treat patients with Hemophilia B.
Laboratory Corporation of America Holdings LH News Analytics from Thu, 25 Sep 2014 07:00:00 GMT to Sat, 18 Jan 2025 11:32:50 GMT -
Rating 5
- Innovation 6
- Information 6
- Rumor 3
